Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,456 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,550 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00403000 | Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | completed | Phase 2 | 27 | Roswell Park Cancer InstituteOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00385580 | Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer | completed | Phase 2 | 94 | Bristol-Myers SquibbINDUSTRY | 3 | Apr 30, 2013 | clinicaltrials |
| NCT01020604 | PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients(PROTECT-Z) | completed | — | 1,376 | AstraZenecaINDUSTRY | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT01839994 | Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer | unknown | Phase 3 | 350 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01664728 | An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 | completed | Phase 1 | 54 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00600535 | A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer | completed | Phase 1 | 31 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Apr 17, 2013 | clinicaltrials |
| NCT00924469 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer | completed | Phase 2 | 58 | Janssen Research & Development, LLCINDUSTRY | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00011349 | Early Stage Prostate Cancer Cohort | completed | — | 1,116 | US Department of Veterans AffairsFED | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00910754 | A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 33 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT01017939 | A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 34 | Janssen Research & Development, LLCINDUSTRY | 2 | Apr 12, 2013 | clinicaltrials |
| NCT00313781 | Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) | completed | Phase 2 | 204 | PfizerINDUSTRY | 6 | Apr 11, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01012141 | Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer(PROTAXY) | completed | Phase 2 | 30 | Centre Jean PerrinOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01827813 | Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies | completed | N/A | 74 | TC Erciyes UniversityOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00243048 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 70 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01825642 | Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer | completed | Phase 2 / Phase 3 | 140 | University of MichiganOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00039299 | Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00046826 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy | completed | Phase 2 | — | Nuvance HealthOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01819285 | Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer | completed | Phase 3 | 985 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Mar 27, 2013 | clinicaltrials |
| NCT00005623 | Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer | completed | Phase 3 | — | Barr LaboratoriesINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00036933 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT01814150 | The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | unknown | — | 200 | Gottfried MayaOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00004211 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 17 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00010127 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 1 | 3 | Duke UniversityOTHER | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00451958 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 3 | 386 | Ferring PharmaceuticalsINDUSTRY | 12 | Mar 21, 2013 | clinicaltrials |
| NCT00666926 | Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | completed | Phase 1 | 99 | Verastem, Inc.INDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00332280 | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 2 | Mar 20, 2013 | clinicaltrials |
| NCT00003819 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | completed | Phase 1 | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00016146 | Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | completed | Phase 1 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01344564 | Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide | completed | N/A | 50 | Urology of VirginiaOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT01813097 | Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer | completed | — | 60 | Chinese PLA General HospitalOTHER | 0 | Mar 18, 2013 | clinicaltrials |
| NCT00314782 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 3 | Mar 12, 2013 | clinicaltrials |
| NCT00244998 | Fulvestrant in Treating Patients With Advanced Prostate Cancer | completed | Phase 2 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT01478308 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | New Mexico Cancer Research AllianceOTHER | 0 | Mar 6, 2013 | clinicaltrials |
| NCT00002848 | Group Therapy Compared With Educational Materials in Patients With Prostate Cancer | completed | N/A | 480 | Gary MorrowOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00213694 | PROSTACOX : Metastatic Prostate Chemotherapy | completed | — | 52 | University Hospital, RouenOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00589966 | Coping in African American Prostate Cancer Survivors(CAAPS) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Mar 1, 2013 | clinicaltrials |
| NCT00002723 | Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 390 | National Cancer Institute (NCI)NIH | 2 | Feb 28, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00103337 | Cilengitide in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 106 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01522118 | MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease | completed | Phase 1 | 12 | University of Roma La SapienzaOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01672411 | Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer | completed | — | 250 | University Of PerugiaOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00869739 | Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer | completed | N/A | 112 | East Carolina UniversityOTHER | 1 | Feb 25, 2013 | clinicaltrials |
Data updated 24 days agoSource updated May 1, 2013source: clinicaltrials